Genedrive Share Discussion Threads

[bones698] 20/11/2024 20:40

Yes bottom of an increasing low and back to 2.9p range . Easy to trade but be careful not to miss out of news comes .

[lawson27] 20/11/2024 11:32

on the move again off 2.30, GLA

[batiatus] 20/11/2024 10:27

Another day with no sales?

[m_night10] 20/11/2024 08:24

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[batiatus] 19/11/2024 11:05

"7-10p short term target written in the charts."

Based on what?

The share price is currently 5% down!!!

[the technical trader] 19/11/2024 10:41

7-10p short term target written in the charts. Something must be in the pipeline.

[kingston78] 19/11/2024 10:30

So many small AIMS companies could only muster a placing of shares raising only £1 million or less in difficult markets. There is little appetite of retail investors. £1 million does not last for long for administrative expenses (including salary and usual overheads). There is little left for development of its products or services.
There will be little or no progress for the company as a whole. The company will keep on raising more money via further discounted placing, diluting existing investors. The cycle repeats itself.

That is the reality. Such companies can dream on; only a tiny minority of them will make it and become successful.

[batiatus] 19/11/2024 10:26

Looking ahead into the future, it'll be like:

It's now 2027 and GDR still have no more sales.

No it won't, because if that was the case then GDR wouldn't be around anymore.

[m_night10] 19/11/2024 07:34

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[premium beeks] 18/11/2024 17:42

At least while you clowns are posting here, you aren't annoying other people.Meanwhile, price continues to strengthen.

[batiatus] 18/11/2024 17:40

"Another day has passed by without more sales."

So true. The BOD are an embarrassment for not closing any sales.

Even a sales boy would have done better with cold calling potential clients.

[petersinthemarket] 18/11/2024 17:18

Another one for the bin

[m_night10] 18/11/2024 15:36

VRCI 10p+ move to come now 3.5p

[stockmaiden] 18/11/2024 13:34

Buy some MATD now.

MATD has good chance to multi-bag in the coming weeks.

Petro China JV deal to fully develop Heron oil field next door could see the share price go to 10-40p

Just like GGP with the new crest JV, lifted the share price from 2p to 40p.

[premium beeks] 18/11/2024 13:15

Doesn't take a lot of buying to push it Northwards.

[stockmaiden] 18/11/2024 12:48

Buy some Petrol Matad instead. share price has over reacted and dropped over 40% last week.

Matad is about to become a producer, looking at around 500-800+bopd.

Company is debt free. They have backing from Petrovis. Petro China (Chinese oil major) deal is being finalised.

[kingston78] 18/11/2024 12:00

Another day has passed by without more sales. A hotel, restaurant or a clothes retailer would have folded already if there were no customers.

Shops have Xmas displays already, so December will soon arrive. Wait for a new dawn in 2025 when a discounted placing will be announced in March 2025, as there will be no further sales in January and February. There will be another announcement that the current CEO has tendered his resignation.

[batiatus] 18/11/2024 11:32

Are there any sales yet?

[petersinthemarket] 18/11/2024 10:26

What a stupid thing to say

[hazl] 18/11/2024 07:33

We certainly know they are busy in the background!

[m_night10] 18/11/2024 07:21

POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval.

Massive takeover target and will be sold for 20p+ share price.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

[hazl] 17/11/2024 17:31

With the products dispersal in various parts of the NHS and even being named as Genedrive....which is very pleasing.... there has to be some sort of acknowledgement and announcement soon, I would have thought.

Amusing to see the sister thread talking about everything but Genedrive!


IMO